Insights into the epidemiology and management of lupus nephritis from the US rheumatologist's perspective

Kidney Int. 2016 Sep;90(3):487-92. doi: 10.1016/j.kint.2016.03.042. Epub 2016 Jun 22.

Abstract

Lupus nephritis is a common and severe manifestation of systemic lupus erythematosus that disproportionately affects nonwhites and those in lower socioeconomic groups. This review discusses recent data on the incidence, prevalence, and outcomes of patients with lupus nephritis with a focus on low-income US Medicaid patients. We also review recent guidelines on diagnosis, treatment, and screening for new onset and relapses of lupus nephritis. Finally, we discuss the management of lupus nephritis from a rheumatologist's perspective, including vigilance for the common adverse events related to disease and treatment, and we review prevention and new treatment strategies.

Keywords: epidemiology; glomerulonephritis; lupus.

Publication types

  • Review
  • Research Support, N.I.H., Extramural

MeSH terms

  • Administration, Oral
  • Chemotherapy, Adjuvant
  • Glucocorticoids / administration & dosage
  • Glucocorticoids / adverse effects*
  • Glucocorticoids / therapeutic use
  • Health Services Accessibility*
  • Humans
  • Immunosuppressive Agents / administration & dosage
  • Immunosuppressive Agents / adverse effects
  • Immunosuppressive Agents / therapeutic use*
  • Incidence
  • Lupus Nephritis / diagnosis
  • Lupus Nephritis / drug therapy*
  • Lupus Nephritis / epidemiology*
  • Medicaid
  • Medication Adherence
  • Practice Guidelines as Topic
  • Prevalence
  • Rheumatologists
  • Risk Factors
  • Socioeconomic Factors
  • Treatment Outcome
  • United States

Substances

  • Glucocorticoids
  • Immunosuppressive Agents